Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Regulation News: Breaking Regulation News, Comments and Articles. - Page: 3

04:20 EDT 23rd April 2014 | BioPortfolio

Regulation News - Page: 3RSS

Read the latest Regulation News from around the world, updated every five minutes. Breaking stories from leading news and press agencies, bloggers and experts on Regulation.

Search or Follow Our Regulation - Page: 3 News…

If you are looking for more stories, you may wish to search our extensive news archives for relevant stories: Search for More Regulation - Page: 3 News.

Showing "regulation regulatory" News Articles 51 to 75 of 6,400+

Tuesday 22nd April 2014

PharmaPoint: Prophylactic Hepatitis B Virus Vaccines - Current and Future Players

Recently added to the BioPortfolio report store, PharmaPoint: Prophylactic Hepatitis B Virus Vaccines - Current and Future Players is a new report from GlobalData published on 2014-01-30. This 70-page report is available in PDF from $2995. PharmaPoint: Prophylactic Hepatitis B Virus Vaccines - Current and Future Players Summary GlobalData has released its pharma report, “PharmaPoint: Prophylac...

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Malaysia

Recently added to the BioPortfolio report store, CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Malaysia is a new report from GlobalData published on 2014-04-14. This 205-page report is available in PDF from $1995. CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Malaysia Summary GlobalData, the industry analysis specialist, has released its latest report, ...

PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2022

Recently added to the BioPortfolio report store, PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2022 is a new report from GlobalData published on 2014-02-27. This 328-page report is available in PDF from $9995. PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2022 Summary During the forecast period from 2012–2022, the growth of the UC...

Monday 21st April 2014

Epistem Announces Further Partnership With The University of Manchester

MANCHESTER, UNITED KINGDOM -- (Marketwired) -- 04/22/14 -- Epistem Holdings Plc (LSE: EHP)(AIM: EHP.L), Manchester, UK, the UK biotechnology and personalised medicine company, announce a further partnership with The University of Manchester to further the understanding of the biology of chronic delayed wound healing associated with skin ulcers. The team, led by Dr Matthew Hardman have been awar...

Supreme Secures Option to Purchase Producing Medical Marijuana Facility

VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 04/22/14 -- Supreme Pharmaceuticals Inc. (the "Company") (OTCBB: SPRWF)(CSE: SL) is pleased to announce that after completion of its due diligence and the completion of other conditions, it has acquired the previously announced option with respect to the producing medical marijuana facility in the South Okanagan for $150,000.00 in cash and $100,000...

Sernova's Cell Pouch(TM) Diabetes Clinical Trial Demonstrates Interim Safety and Biocompatibility

LONDON, ONTARIO -- (Marketwired) -- 04/22/14 -- Sernova Corp. (TSX VENTURE: SVA), a clinical stage company developing medical technologies for the long-term treatment of chronic metabolic diseases including diabetes, blood disorders such as haemophilia and other diseases, today announced interim results in an ongoing type 1 diabetes human clinical trial with the Company's Cell Pouch™. Sernova'...

Neuronascent Successfully Completes Pre-IND Meeting With FDA for Alzheimer's Disease Therapeutic

CLARKSVILLE, MD -- (Marketwired) -- 04/22/14 -- Neuronascent, Inc. (www.neuronascent.com), a company focused on developing its novel therapeutic candidates for new neuron formation in Alzheimer's disease (AD), Parkinson's disease and Down syndrome, announced today that the company successfully completed a pre-investigational new drug (PIND) meeting with the FDA for their AD therapeutic candidate,...

BrainStorm Hosting Conference Call to Update Shareholders on Important Developments

NEW YORK, NY and PETAH TIKVA, ISRAEL -- (Marketwired) -- 04/22/14 -- BrainStorm Cell Therapeutics (OTCQB: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, announced today that it will hold a conference call on Monday, April 28, 2014 at 8:45 a.m. Eastern Daylight Time (EDT), 15:45 Israel Daylight Time (IDT). Mr. Chaim Lebovits, BrainStorm's President and...

Adherex Announces Two Sodium Thiosulfate Presentations for Prevention of Ototoxicity in Children at ASCO Meeting

RESEARCH TRIANGLE PARK, NORTH CAROLINA -- (Marketwired) -- 04/22/14 -- Adherex Technologies, Inc. (TSX: AHX)(OTCQB: ADHXF) today announced that both of the Phase III studies being conducted on Sodium Thiosulfate (STS) have been accepted for presentation at the 2014 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois. David Freyer, DO, MS, Childrens Hospital Los Ange...

GSK and Theravance Announce Phase III Study of Fluticasone Furoate/Vilanterol in COPD Commenced to Support Potential Future Filing in Japan

LONDON, UNITED KINGDOM and SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 04/22/14 -- GlaxoSmithKline (LSE: GSK) (NYSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced the start of a Phase III efficacy and safety study of a combination treatment of the inhaled corticosteroid (ICS), fluticasone furoate and long-acting beta2 agonist (LABA), vilanterol (FF/VI). The study will evaluate the cont...

Nuvilex, Inc. Applying for Orphan Drug Status to Market Pancreatic Cancer Treatment Without Competition

NEW YORK, NY -- (Marketwired) -- 04/22/14 -- When Nuvilex, Inc. (OTCQB: NVLX) named Clinical Network Services (CNS) as the Contract Research Organization (CRO) for its late phase clinical trials in advanced pancreatic cancer, the company also stated it will apply for "Orphan Drug" status. This is a designation that will allow Nuvilex to exclusively market its pancreatic cancer treatment using the...

Patient Home Monitoring (PHM) Appoints its Chairman Michael Dalsin as Chief Executive Officer

SAN FRANCISCO, CALIFORNIA -- (Marketwired) -- 04/22/14 -- Patient Home Monitoring ("PHM") (TSX VENTURE: PHM), a profitable company focused on rolling-up annuity-based healthcare service companies in the US and Canada, today announced that it has appointed Chairman Michael Dalsin to the concurrent position of Chief Executive Officer effective immediately. Mr. Andrew Folmer will remain as Presiden...

LED Imaging Partners with The University of Tennessee Health Science Center College of Dentistry to Provide Students with Advanced Imaging Technology

BURNABY, BRITISH COLUMBIA -- (Marketwired) -- 04/22/14 -- LED Medical Diagnostics Inc. ("LED Medical" or the "Company") (TSX VENTURE: LMD)(OTCQX: LEDIF)(FRANKFURT: LME) is pleased to announce that the LED Imaging Division of its wholly-owned US operating subsidiary, LED Dental Ltd. ("LED Dental") has entered a partnership with the UT College of Dentistry. Through this partnership, students, resid...

CNS to help plan pancreatic cancer trial

Australian CRO Clinical Network Services (CNS) has been contracted by Nuvilex to help plan a trial of a prospective new treatment for inoperable pancreatic cancer.Under the agreement, CNS will provide Australian clinical and global regulatory services in support of a treatment built from Nuvilex’s Cell in a Box technology.Cell in a Box is a cellulose-based, live-cell encapsulation technology...

PETA science consortium to present hazard testing strategy at nanotoxicology meeting

(People for the Ethical Treatment of Animals) PETA International Science Consortium will present a non-animal tiered-testing strategy for nanomaterial hazard assessment at the 7th International Nanotoxicology Congress being held in Antalya, Turkey on...

Provista brings in $6mm through Series B round

Provista Diagnostics Inc. (molecular diagnostics for women's cancers) raised $6mm from 34 existing investors in its Series B round. The company will use the funds to boost commercialization efforts for its dtectDx-Breast breast cancer assay, and to p...

Research Report on Micro-RNA Market Analysis, Trends And Forecast, 2013 - 2019

Transparency Market Research Report Added "Research Report on Micro-RNA Market Analysis, Trends And Forecast, 2013 - 2019" to its database. Browse Full Report: http://www.transparencymarketresearch.com/micro-rna-market.html. Albany, New York, USA (PRWEB) April 21, 2014 Transparency Market Research Reports included a detailed market survey and analysis trends on “Micro-RNA Market”. T...

Sarepta Therapeutics Regulatory Update Call Transcript

Sarepta Therapeutics, Inc. (SRPT) Regulatory Update Conference Call April 18, 2014 08:00 AM ET Executives Erin Cox - Manager, IR Chris Garabedian - President and CEO Ed Kaye - CMO Analyst Ritu Baral - Canaccord Genuity Brian Skorney - Robert W. Baird & Co. Mohit Bansal - Deutsche Bank Liisa Bayko - JMP Securities Ted Tenthoff - Piper Jaffray Brian Klein - Stifel Nicolaus Chris Marai -...

Sarepta Therapeutics CEO Discusses Regulatory Update (Transcript)

Sarepta Therapeutics, Inc. (SRPT) Regulatory Update Conference Call April 21, 2014 08:00 AM ET Executives Erin Cox - Manager, IR Chris Garabedian - President and CEO Ed Kaye - CMO Analyst Ritu Baral - Canaccord Genuity Brian Skorney - Robert W. Baird & Co. Mohit Bansal - Deutsche Bank Liisa Bayko - JMP Securities Ted Tenthoff - Piper Jaffray Brian Klein - Stifel Nicolaus Chris Marai...

Transvaginal Mesh Lawsuit News: FDA Inspection of American Medical Systems Manufacturing Facility Leads to Warning Letter, Bernstein Liebhard LLP Reports

NEW YORK, April 21, 2014 /PRNewswire/ -- As thousands of transvaginal mesh lawsuits (http://www.transvaginalmeshlawsuithelp.com/) filed against American Medical Systems, Inc. continue to move forward in federal court, Bernstein Liebhard LLP notes that a manufacturing facility operated by the company was recently the subject of a warning letter issued by the U.S. Food & Drug Administration (FDA...

DGAP-Regulatory: Nokia expects the sale of substantially all of its Devices & Services business to Microsoft to close on April 25, 2014

Nokia / Miscellaneous 21.04.2014 15:54 Dissemination of a Regulatory Announcement, transmitted by DGAP - a company of EQS Group AG. The issuer is solely responsible for the content of this announc...

PPD Adds Experienced Leader to Enhance Delivery of Innovative Solutions

Pharmaceutical Product Development, LLC (PPD) today announced the addition of Bhooshi De Silva as senior vice president of corporate development and strategy to its executive leadership team. De Silva will focus on key strategic initiatives vital to supporting PPD’s growth and client success, including corporate development, strategy and mergers and acqu...

DIA 2014 50th Annual Meeting to Explore Regulatory Challenges for Orphan Medicines

Symposium to highlight how legislation in Europe and U.S. can help bring medicines to market “Regulatory Challenges for Orphan Medicines,” a symposium that features presentations by a number of industry experts, will take place during the DIA 2014 50th Annual Meeting at the San Diego Convention Center from

PHT Corporation Appoints Andrea Valente Chief Operating Officer

PHT Vice President with 20+ years of clinical software expertise promoted for excellence in supporting customers’ use of eClinical Systems for patient-focused research PHT Corporation announced the promotion of Vice President of Service Delivery

Mallinckrodt plc to Report Second Quarter Results on May 8, 2014

Mallinckrodt plc (NYSE: MNK) will report second quarter results on Thursday, May 8, 2014. The company will hold a conference call for investors from 7:30-8:00am, U.S. Eastern Time. Shortly after the earnings call, the company will hold a separate “live” fireside chat question and answer session for investors at the St. Regis New York, 2 East 55th...


Search BioPortfolio:
Advertisement

News Quicklinks

Advertisement